Mankind Pharma (BOM:543904) Total Assets : ₹119,633 Mil (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma Total Assets?

Mankind Pharma's Total Assets for the quarter that ended in Mar. 2024 was ₹119,633 Mil.

During the past 3 years, the average Total Assets Growth Rate was 24.80% per year.

During the past 5 years, Mankind Pharma's highest 3-Year average Total Assets Growth Rate was 24.80%. The lowest was 24.80%. And the median was 24.80%.

Total Assets is connected with ROA %. Mankind Pharma's annualized ROA % for the quarter that ended in Mar. 2024 was 15.76%. Total Assets is also linked to Revenue through Asset Turnover. Mankind Pharma's Asset Turnover for the quarter that ended in Mar. 2024 was 0.20.

Mankind Pharma Total Assets Historical Data

The historical data trend for Mankind Pharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma Total Assets Chart

Mankind Pharma Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Total Assets

50,732.85

63,726.32

91,477.40

119,632.55

Mankind Pharma Quarterly Data
	Mar20	Mar21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial							-	-	110,983.24	-	119,632.55

Mankind Pharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Mankind Pharma's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (A: Mar. 2024 )	+	Total Liabilities (A: Mar. 2024 )
	=	95757.881	+	23874.666
	=	119,633

Mankind Pharma's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	95757.881	+	23874.666
	=	119,633

Mankind Pharma (BOM:543904) Total Assets Explanation

Total Assets is connected with ROA %.

Mankind Pharma's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	18849.54	/	( (0	+	119632.547)	/ 1 )
	=	18849.54	/	119632.547
	=	15.76 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Mankind Pharma's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	24410.992	/	( (0	+	119632.547)	/ 1 )
=	24410.992	/	119632.547
=	0.20

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Mankind Pharma Total Assets Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Mankind Pharma (BOM:543904) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » Total Assets

Traded in Other Exchanges

MANKIND:India

Address

262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020

Website

https://www.mankindpharma.com

Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines